Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
24
pubmed:dateCreated
2001-1-18
pubmed:abstractText
Decreased levels of the cyclin-dependent kinase inhibitor p27(Kip1) in breast cancer are associated with a poor outcome. The prognostic significance of BRCA1/2 mutations is less clear, and the relationship between BRCA1/2 mutation status, p27(Kip1) protein levels, and outcome has not been studied.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0732-183X
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
18
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4045-52
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:11118465-Adult, pubmed-meshheading:11118465-Analysis of Variance, pubmed-meshheading:11118465-BRCA2 Protein, pubmed-meshheading:11118465-Breast Neoplasms, pubmed-meshheading:11118465-Cell Cycle Proteins, pubmed-meshheading:11118465-Cohort Studies, pubmed-meshheading:11118465-Cyclin-Dependent Kinase Inhibitor p27, pubmed-meshheading:11118465-Disease-Free Survival, pubmed-meshheading:11118465-Female, pubmed-meshheading:11118465-Follow-Up Studies, pubmed-meshheading:11118465-Genes, BRCA1, pubmed-meshheading:11118465-Genetic Predisposition to Disease, pubmed-meshheading:11118465-Germ-Line Mutation, pubmed-meshheading:11118465-Humans, pubmed-meshheading:11118465-Immunohistochemistry, pubmed-meshheading:11118465-Jews, pubmed-meshheading:11118465-Microtubule-Associated Proteins, pubmed-meshheading:11118465-Middle Aged, pubmed-meshheading:11118465-Neoplasm Proteins, pubmed-meshheading:11118465-Predictive Value of Tests, pubmed-meshheading:11118465-Retrospective Studies, pubmed-meshheading:11118465-Survival Rate, pubmed-meshheading:11118465-Transcription Factors, pubmed-meshheading:11118465-Tumor Suppressor Proteins
pubmed:year
2000
pubmed:articleTitle
Germline BRCA1/2 mutations and p27(Kip1) protein levels independently predict outcome after breast cancer.
pubmed:affiliation
Department of Medicine, Sir M.B. Davis-Jewish General Hospital, McGill University Health Centre Research Institute, McGill University, Montreal, Quebec, Canada.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't